{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:49:30Z","timestamp":1763664570454,"version":"3.37.3"},"reference-count":21,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2021,5,12]]},"DOI":"10.1080\/10428194.2021.1919662","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T18:45:53Z","timestamp":1620585953000},"page":"1325-1334","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma"],"prefix":"10.1080","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-036X","authenticated-orcid":false,"given":"Ravi K.","family":"Goyal","sequence":"first","affiliation":[{"name":"Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preetesh","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh P.","family":"Nagar","sequence":"additional","affiliation":[{"name":"Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Le","sequence":"additional","affiliation":[{"name":"US HEOR Oncology, AstraZeneca, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaum M.","family":"Kabadi","sequence":"additional","affiliation":[{"name":"Epidemiology and Real-World Evidence in Oncology, AstraZeneca, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, RTI Health Solutions, Waltham, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin L.","family":"Du","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-5486","authenticated-orcid":false,"given":"Michael","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22367"},{"key":"CIT0002","unstructured":"National Comprehensive Cancer Network (NCCN) [Internet]. Clinical practice guidelines in oncology: B-cell lymphomas. Version 1. 2017. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2020. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1509320"},{"issue":"19","key":"CIT0004","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1158\/1538-7445.AM2014-4139","volume":"74","author":"Kozma CM","year":"2014","journal-title":"Cancer Res"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348367"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.01.006"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001723"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000486"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0059"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27638"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30187-9"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25487"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0470"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25707"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2559"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv111"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00447-7"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-635326"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"CIT0021","unstructured":"Imbruvica (ibrutinib). Prescribing information; 2020; [cited 2020 Mar 31]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/205552s030,210563s006lbl.pdf"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2021.1919662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T20:33:24Z","timestamp":1672086804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2021.1919662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5,12]]}},"alternative-id":["10.1080\/10428194.2021.1919662"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2021.1919662","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}